# Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study

> **NCT01212432** · PHASE2 · UNKNOWN · sponsor: **University of Zurich** · enrollment: 15 (estimated)

## Conditions studied

- Gram-Positive Bacterial Infections

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT01212432
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2010-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212432, "Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01212432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*